← Eichor
Study identifier: NCT05402696 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)

Condition: Colon Adenoma · Colon Polyp · Colon Lesion  ·  Sponsor: University of British Columbia

PhaseN/A
Planned participants3500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The SPARC-C study is a prospective, multi-institutional observational study of patients referred for the management of large (≥ 20mm) non-pedunculated colorectal polyps (LNPCPs). Patients are managed consistent with current standards of care. Prospectively collected data includes: patient clinicodemographic details, lesion details, procedural details, and clinical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Shirley X Jiang, MD  ·  (604) 688-6332  ·  sjiangx@alumni.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (6)

St. Cloud HospitalSaint Cloud, Minnesota, United StatesRecruiting
Mount Saint Joseph HospitalVancouver, British Columbia, CanadaActive Not Recruiting
Vancouver General HospitalVancouver, British Columbia, CanadaRecruiting
St. Paul's HospitalVancouver, British Columbia, CanadaRecruiting
Pacific Gastroenterology AssociatesVancouver, British Columbia, CanadaRecruiting
Hadassah Ein Kerem HospitalJerusalem, IsraelActive Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05402696